Non-invasive cardiac imaging for evaluation of cardiotoxicity in cancer patients - early detection and follow-up
Cardiotoxicity is an increasingly important clinical entity that occurs as a result of untoward, and incompletely understood, effects on cardiac function. It is primarily caused by the anthracycline agents (doxorubicin, daunorubicin) but has also been observed with monoclonal antibody agents such as...
Guardado en:
Autores principales: | Gabriel Vorobiof, Cheri Silverstein |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
South African Heart Association
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da5479581fcd4cb0840c87c8d24f1fbb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Non-invasive cardiac output monitoring (NICOM) in adult congenital heart disease patients with Fontan palliation
por: Angela Quain, et al.
Publicado: (2021) -
Using biomarkers and early prophylactic treatment to prevent cardiotoxicity in cancer patients on chemotherapy
por: Giulia Bacchiani, et al.
Publicado: (2017) -
The Use of App-based Follow-up of Cardiac Implantable Electronic Devices
por: Paul Richard Roberts, et al.
Publicado: (2020) -
The Role of METTL3-Mediated N6-Methyladenosine (m6A) of JPH2 mRNA in Cyclophosphamide-Induced Cardiotoxicity
por: Min Zhu, et al.
Publicado: (2021) -
The Role of 6-Minute Walk Test Guided by Impedance Cardiography in the Rehabilitation Following Knee Arthroplasty: A Randomized Controlled Trial
por: Yangyang Lin, et al.
Publicado: (2021)